Learning ..
" A BIG questions remains : who pays for the 924,530. "
Yes who pays ?? lets see again what is going on with treatment in USA..
Lets see again our results in group B of our CD12 study ..and all the SOC drugs use for treatment..
Even with sabotaged by FDA study , with only 2 injections of leronlimab at 0 and 7 days, results are very clear.
Everyone with minimal understanding of any study will see how great , lives saving leronlimab is , there is no question about it.
At 7 days there was 78% mortality benefit ABOVE ALL SOC drugs ...
At 14 days , it was 82% ,
82 % mortality benefit , how much smaller the death number will be.
Leronlimab given SC has 10 days half life..So at 28 days there was no more drug in the system , FDA know that , and they made 28 days primary endpoint , moved from 14 days in the protocol , first reducing 4 weeks treatment to 2.
Last shot at 7 days and primary endpoint at 28... how convenient if one want study to fail..
But even at 28 days where there was no more leronlimab in the system , mortality benefit was 31% ABOVE all SOC drugs..
All these results are VERY easy to see and understand..
And not one serious side effect with leronlimab..
Lets talk now about drugs approved and use as SOC..
--Dexamethasone , it is a very strong immunosuppressant , but definitely delay need for a ventilator..
--Remdesivir , one of the most toxic drug , especially on kidney , show minimal benefit in covid , and only when study done by Dr Fauci or Gilead..
When WHO did a very big study it showed ...
......No mortality benefits and no change in length of hospitalization....
Some countries stopped using this toxic drug all together , but in USA gov paying hospitals 20% above the price if they use remdesivir , so EVERY patients in every stage of covid receiving remdesivir on admission , patient need to REFUSE strongly not to get it , and how many sick people will understand to do this..
Then there is..
--Tocilizumab, many studies they did failed , so then they did many very large studies, and in some it showed minimal improvement , it is ONLY IL6 inhibitor , and covid is much more then that ..
and severe side effects , are really severe : it is immunosuppressant , may produce heart attack , heart failure , interstitial lung disease , pancreatitis , liver damage , All together over 500,000 serious side effects reported to FDA. And all this with minimal efficacy in covid ..
--Baricitinib , another drug in SOC with minimal efficacy and severe side effects like :
immunosuppression , deep vain and arterial thrombosis , gastrointestinal perforation , liver , kidney injury..
Yes here we are in the critical patients , leronlimab without one serious side effect , with 82% mortality benefits above ALL THESE TOXIC SOC drugs with very minimal efficacy.
And which one is approved by FDA , no , not leronlimab..
There is a reason for almost 1 M Americans death in the last 2 years , and most of people died in the last 1 year , the more SOC drugs are use , the more are dying...
I will say , stop treating these patients , they will have a better chance to survive..and I hope that one day soon guilty will pay ..
All imo.
AI
